Shopping Cart
- Remove All
- Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | ELOVL6-IN-4 is a potent and selective long chain fatty acid elongase 6 (ELOVL6) inhibitor that is orally active, with IC50 values of 79 nM for human ELOVL6 and 94 nM for mouse ELOVL6. It demonstrates excellent selectivity over other human ELOVL subtypes (ELOVL1, -2, -3, and -5) and mouse ELOVL3 [1]. |
In vitro | ELOVL6-IN-4 (compound 1w) effectively reduces the elongation index in mouse hepatocytes H2.35, with an IC₅₀ of 30 nM. |
In vivo | ELOVL6-IN-4 (compound 1w; 1-10 mg/kg; oral administration, single dose) effectively and dose-dependently inhibits the elongation index in the liver of male C57BL/6J mice [1]. Dosage: 1 mg/kg, 3 mg/kg, and 10 mg/kg; Administration: Oral, single dose. Result: Significant inhibition of hepatic elongation index. |
Molecular Weight | 439.45 |
Formula | C20H20F3N3O3S |
Cas No. | 1170321-92-2 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.